Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | USPH |
---|---|---|
09:32 ET | 888 | 98.98 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
US Physical Therapy Inc | 1.5B | 105.8x | -0.50% |
Pennant Group Inc | 1.1B | 45.6x | -5.49% |
LTC Properties Inc | 1.8B | 16.9x | -11.14% |
OPKO Health Inc | 1.1B | -8.8x | --- |
Neogenomics Inc | 2.1B | -27.2x | --- |
National Healthcare Corp | 2.0B | 16.1x | +1.85% |
U.S. Physical Therapy, Inc. is a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services. Its physical therapy operations segment primarily operates through subsidiary clinic partnerships. Its physical therapy operations consist of physical therapy and occupational therapy clinics that provide pre- and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries. Services provided by the industrial injury prevention services segment include onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional evaluations and ergonomic assessments. It owns and/or manages approximately 750 outpatient physical therapy clinics in 43 states. It also has an industrial injury prevention business which provides onsite services for clients’ employees.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.5B |
---|---|
Revenue (TTM) | $645.7M |
Shares Outstanding | 15.1M |
Dividend Yield | 1.78% |
Annual Dividend Rate | 1.7600 USD |
Ex-Dividend Date | 11-15-24 |
Pay Date | 12-06-24 |
Beta | 1.45 |
EPS | $0.94 |
Book Value | $31.77 |
P/E Ratio | 105.8x |
Price/Sales (TTM) | 2.3 |
Price/Cash Flow (TTM) | 30.2x |
Operating Margin | 7.40% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.